1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol has been researched along with Age-Related Memory Disorders in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chocyk, A; Dudys, D; Maćkowiak, M; Wedzony, K | 1 |
Bromley-Brits, K; Cai, F; Chen, B; He, G; Song, W; Zhang, X | 1 |
Christie, BR; Fox, CJ; Froc, DJ; Gorzalka, BB; Hill, MN | 1 |
Chocyk, A; Maćkowiak, M; Markowicz-Kula, K; Wedzony, K | 1 |
Goonawardena, AV; Hampson, RE; Pertwee, RG; Riedel, G; Robinson, L | 1 |
5 other study(ies) available for 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol and Age-Related Memory Disorders
Article | Year |
---|---|
Activation of CB1 cannabinoid receptors impairs memory consolidation and hippocampal polysialylated neural cell adhesion molecule expression in contextual fear conditioning.
Topics: Animals; Conditioning, Psychological; Dentate Gyrus; Doublecortin Domain Proteins; Doublecortin Protein; Dronabinol; Fear; Freezing Reaction, Cataleptic; Gene Expression; Ki-67 Antigen; Male; Memory Disorders; Microtubule-Associated Proteins; Neural Cell Adhesion Molecule L1; Neuropeptides; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Sialic Acids | 2009 |
Effect of synthetic cannabinoid HU210 on memory deficits and neuropathology in Alzheimer's disease mouse model.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Brain; Cannabinoid Receptor Modulators; Cognition Disorders; Conditioning, Psychological; Disease Models, Animal; Dronabinol; Female; Humans; Male; Maze Learning; Memory; Memory Disorders; Mice; Mice, Transgenic; Neuroprotective Agents; Plaque, Amyloid; Treatment Failure | 2010 |
Prolonged cannabinoid treatment results in spatial working memory deficits and impaired long-term potentiation in the CA1 region of the hippocampus in vivo.
Topics: Animals; Behavior, Animal; Cannabinoids; Dronabinol; Electrophysiology; Hippocampus; Long-Term Potentiation; Male; Maze Learning; Memory Disorders; Memory, Short-Term; Rats; Rats, Long-Evans; Reaction Time; Time; Time Factors | 2004 |
Acute activation of CB1 cannabinoid receptors transiently decreases PSA-NCAM expression in the dentate gyrus of the rat hippocampus.
Topics: Animals; Cannabinoids; Cell Count; Cell Differentiation; Cell Proliferation; Dentate Gyrus; Dose-Response Relationship, Drug; Doublecortin Domain Proteins; Doublecortin Protein; Down-Regulation; Dronabinol; Excitatory Amino Acid Antagonists; Immunohistochemistry; Ki-67 Antigen; Male; Memory Disorders; Microtubule-Associated Proteins; Neural Cell Adhesion Molecule L1; Neuronal Plasticity; Neurons; Neuropeptides; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Sialic Acids; Stem Cells; Time Factors | 2007 |
The synthetic cannabinoid HU210 induces spatial memory deficits and suppresses hippocampal firing rate in rats.
Topics: Animals; Behavior, Animal; Cannabinoids; Dronabinol; Electrophysiology; Hippocampus; Male; Maze Learning; Memory; Memory Disorders; Morpholines; Motor Activity; Neurons; Piperidines; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Rimonabant; Space Perception | 2007 |